New insights into the pathophysiology of methylmalonic acidemia

Area of Science:

• Biochemistry
• Metabolic Disorders
• Molecular Biology

Background:

• Methylmalonic acidemia (MMA) is a severe inherited metabolic disorder with widespread effects.
• Current treatments for MMA are limited and do not cure the disease, as its fundamental molecular causes are not fully understood.

Purpose of the Study:

• To investigate the role of aberrant protein acylation, specifically methylmalonylation, in the pathophysiology of MMA.
• To explore the potential of targeting posttranslational modifications as a novel therapeutic strategy for MMA.

Main Methods:

• Analysis of protein acylation patterns in MMA.
• Assessment of mitochondrial sirtuin enzyme (SIRT3, SIRT4, SIRT5) levels and function in MMA models.
• Investigating the role of SIRT5 in removing methylmalonyl modifications.

Main Results:

• Aberrant protein methylmalonylation is identified as a characteristic feature of MMA.
• Reduced levels and potentially impaired function of mitochondrial sirtuins (SIRT3, SIRT4, SIRT5) are observed in MMA.
• SIRT5 demonstrates the ability to remove methylmalonyl posttranslational modifications.

Conclusions:

• Aberrant acylation, particularly methylmalonylation, is a key pathogenic mechanism in MMA.
• Mitochondrial sirtuins, especially SIRT5, are implicated in regulating these aberrant modifications.
• Targeting posttranslational modifications presents a promising new therapeutic avenue for MMA and related organic acidemias.